Qlife Holding AB (OSTO:QLIFE) Other Stockholders Equity: kr10.79 Mil (As of Mar. 2026)


OSTO:QLIFE Qlife Holding AB OSTO:QLIFE
15 GF Score
Price kr1.83
GF Value kr0.76
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Qlife Holding AB Other Stockholders Equity?

Qlife Holding AB OSTO:QLIFE -4.89% 15 Other Stockholders Equity is kr10.79 Mil as of Mar. 2026. GuruFocus rates OSTO:QLIFE with a GF Score™ of 15/100 and a GF Value™ of kr0.76 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Qlife Holding AB's Other Stockholders Equity for the quarter that ended in Mar. 2026 was kr10.79 Mil.

Qlife Holding AB's quarterly Other Stockholders Equity declined from Sep. 2025 (kr10.79 Mil) to Dec. 2025 (kr-268.53 Mil) but then increased from Dec. 2025 (kr-268.53 Mil) to Mar. 2026 (kr10.79 Mil).

Qlife Holding AB's annual Other Stockholders Equity increased from Dec. 2023 (kr-294.23 Mil) to Dec. 2024 (kr-247.99 Mil) but then declined from Dec. 2024 (kr-247.99 Mil) to Dec. 2025 (kr-268.53 Mil).

Qlife Holding AB Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Qlife Holding AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qlife Holding AB Other Stockholders Equity Chart

Qlife Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 1.08 -135.86 -294.23 -247.99 -268.53

Qlife Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.68 10.79 10.79 -268.53 10.79
OSTO:QLIFE
15GF Score
Qlife Holding AB OSTO:QLIFE
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qlife Holding AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of kr10.79 Mil mean?
Qlife Holding AB (OSTO:QLIFE) has a Other Stockholders Equity of kr10.79 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Qlife Holding AB and its competitors.
Is Qlife Holding AB's Other Stockholders Equity too high?
Qlife Holding AB's current Other Stockholders Equity is kr10.79 Mil. Overall, Qlife Holding AB has a GF Score™ of 15/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qlife Holding AB's Other Stockholders Equity compare to ABT and SYK?
Qlife Holding AB's Other Stockholders Equity of kr10.79 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Qlife Holding AB and its competitors. Qlife Holding AB's current Other Stockholders Equity is kr10.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qlife Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Qlife Holding AB (OSTO:QLIFE) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.76, compared to a current price of kr1.83 — trading 140.5% above its estimated fair value. The current Other Stockholders Equity is kr10.79 Mil. Qlife Holding AB's overall GF Score™ is 15/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Qlife Holding AB (OSTO:QLIFE), the current Other Stockholders Equity is kr10.79 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qlife Holding AB (OSTO:QLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, Qlife Holding AB stock appears to be overvalued. The current stock price of kr1.83 is trading 140.5% above its estimated GF Value™ of kr0.76. GuruFocus considers Qlife Holding AB to be Significantly Overvalued.

Key valuation signals for OSTO:QLIFE:

  • Other Stockholders Equity: kr10.79 Mil
  • GF Value™: kr0.76 vs. price of kr1.83 (140.5% above fair value)
  • GF Score™: 15/100 with 9 warning signs

No single metric tells the full story. See the OSTO:QLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qlife Holding AB Business Description

Other Exchanges 4HG0:Germany
Address Nellikevagen 22, Goteborg, SWE, SE-412 63
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
15GF Score

Get the complete analysis for OSTO:QLIFE

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.83
Price
kr0.76
GF Value